日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites

淋巴结阳性默克尔细胞癌(III期)的生存结果:已知原发肿瘤和未知原发肿瘤及其日光暴露部位的比较

Brenner, Ronen; Edri, Hanna T Frumin; El-Saied, Sabri; Berezhnov, Ilia; Ievko, Anna; Rouvinov, Keren; Turaieva, Sofiia; Meirovitz, Amichay; Tairov, Tanzilya; Fenig, Shlomit; Yasin, Nashat Abu; Yakobson, Alexander; Fenig, Eyal; Agbarya, Abed; Shalata, Walid

Sun-Exposed vs. Non-Sun-Exposed Areas: Epidemiology and Pathogenesis of Non-Metastatic Merkel Cell Carcinoma

日光照射区域与非日光照射区域:非转移性默克尔细胞癌的流行病学和发病机制

Yakobson, Alexander; Brenner, Ronen; Frumin Edri, Hanna T; Ievko, Anna; Turaieva, Sofiia; Tairov, Tanzilya; Berezhnov, Ilia; Fenig, Shlomit; Fenig, Eyal; Ziv-Baran, Tomer; El-Saied, Sabri; Shalata, Walid

Hydrogel Spacer Insertion Prior to Stereotactic Body Radiation Therapy to the Prostate: A Comparative Study

立体定向放射治疗前列腺前植入水凝胶垫片:一项比较研究

Lutsyk, Myroslav; Landman, Yosef; Fenig, Eyal

Worse prognosis of local and locally advanced head and neck Merkel cell carcinoma: Is it time to change the treatment paradigm?

局部和局部晚期头颈部默克尔细胞癌预后较差:是时候改变治疗模式了吗?

Brenner, Ronen; Frumin Edri, Hanna T; Sarel, Ina; Levko, Anna; Turaieva, Sofiia; Tairov, Tanzilya; Berezhnov, Ilia; Fenig, Shlomit; Fenig, Eyal; Ziv-Baran, Tomer; Yakobson, Alexander; Shalata, Walid

Is the Addition of Chemotherapy to Adjuvant Radiation in Merkel Cell Cancer Beneficial? Real-World Data with Long-Term Follow-Up

在默克尔细胞癌的辅助放疗中加入化疗是否有益?来自长期随访的真实世界数据

Shalata, Walid; Edri, Hanna T Frumin; Sarel, Ina; Ievko, Anna; Turaieva, Sofiia; Tairov, Tanzilya; Berezhnov, Ilia; Fenig, Shlomit; Fenig, Eyal; Ziv-Baran, Tomer; Yakobson, Alexander; Brenner, Ronen

Merkel cell carcinoma originating in the gluteal region

臀部起源的默克尔细胞癌

Fennig, Shlomit; Landman, Yosef; Brenner, Ronen; Fenig, Eyal

Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in Israel

Avelumab治疗局部晚期或转移性默克尔细胞癌——以色列多中心真实世界经验

Averbuch, Itamar; Stoff, Ronen; Miodovnik, Mor; Fennig, Shlomit; Bar-Sela, Gil; Yakobson, Alexander; Daliot, Jonathan; Asher, Nethanel; Fenig, Eyal

The initial rate of tumour response to vismodegib treatment, can predict a complete response outcome for periocular LA-BCC

肿瘤对维莫德吉治疗的初始反应率可以预测眼周局部晚期基底细胞癌的完全缓解结果。

Tiosano, Alon; Ben-Ishai, Meydan; Fenig, Eyal; Ben Simon, Guy J; Yassur, Iftach

Merkel cell carcinoma in lymph nodes with and without primary origin

淋巴结默克尔细胞癌,无论原发灶是否转移

Fennig, Shlomit; Landman, Yosef; Brenner, Ronen; Billan, Salem; Fenig, Eyal

Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East

Avelumab 扩大使用计划治疗转移性默克尔细胞癌:来自欧洲和中东患者的疗效和安全性研究结果

Ascierto, Paolo Antonio; Orlova, Kristina; Grignani, Giovanni; Dudzisz-Śledź, Monika; Fenig, Eyal; Chiarion Sileni, Vanna; Fazio, Nicola; Samimi, Mahtab; Mortier, Laurent; Gebhardt, Christoffer; Kramkimel, Nora; Steven, Neil; Bechter, Oliver; Arance, Ana; Benincasa, Elena; Kostkova, Lenka; Costa, Nuno; Lorigan, Paul